These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
378 related items for PubMed ID: 10468941
1. GH replacement in 1034 growth hormone deficient hypopituitary adults: demographic and clinical characteristics, dosing and safety. Abs R, Bengtsson BA, Hernberg-Stâhl E, Monson JP, Tauber JP, Wilton P, Wüster C. Clin Endocrinol (Oxf); 1999 Jun; 50(6):703-13. PubMed ID: 10468941 [Abstract] [Full Text] [Related]
5. The effects of treatment and the individual responsiveness to growth hormone (GH) replacement therapy in 665 GH-deficient adults. KIMS Study Group and the KIMS International Board. Bengtsson BA, Abs R, Bennmarker H, Monson JP, Feldt-Rasmussen U, Hernberg-Stahl E, Westberg B, Wilton P, Wüster C. J Clin Endocrinol Metab; 1999 Nov; 84(11):3929-35. PubMed ID: 10566630 [Abstract] [Full Text] [Related]
9. Serum insulin-like growth factor I (IGF-I), IGF-binding proteins 2 and 3, and the risk for development of malignancies in adults with growth hormone (GH) deficiency treated with GH: data from KIMS (Pfizer International Metabolic Database). Popovic V, Mattsson AF, Gaillard RC, Wilton P, Koltowska-Häggström M, Ranke MB. J Clin Endocrinol Metab; 2010 Sep; 95(9):4449-54. PubMed ID: 20610598 [Abstract] [Full Text] [Related]
11. Influences on quality of life in GH deficient adults and their effect on response to treatment. Murray RD, Skillicorn CJ, Howell SJ, Lissett CA, Rahim A, Smethurst LE, Shalet SM. Clin Endocrinol (Oxf); 1999 Nov; 51(5):565-73. PubMed ID: 10594517 [Abstract] [Full Text] [Related]
12. Baseline characteristics and response to 2 years of growth hormone (GH) replacement of hypopituitary patients with GH deficiency due to adult-onset craniopharyngioma in comparison with patients with nonfunctioning pituitary adenoma: data from KIMS (Pfizer International Metabolic Database). Verhelst J, Kendall-Taylor P, Erfurth EM, Price DA, Geffner M, Koltowska-Häggström M, Jönsson PJ, Wilton P, Abs R. J Clin Endocrinol Metab; 2005 Aug; 90(8):4636-43. PubMed ID: 15928246 [Abstract] [Full Text] [Related]
13. A therapeutic trial of growth hormone in hypopituitary adults and its influence upon continued prescription by general practitioners. Davies JS, Obuobie K, Smith J, Rees DA, Furlong A, Davies N, Evans LM, Scanlon MF. Clin Endocrinol (Oxf); 2000 Mar; 52(3):295-303. PubMed ID: 10718827 [Abstract] [Full Text] [Related]
14. Growth hormone deficiency and replacement in hypopituitary patients previously treated for acromegaly or Cushing's disease. Feldt-Rasmussen U, Abs R, Bengtsson BA, Bennmarker H, Bramnert M, Hernberg-Ståhl E, Monson JP, Westberg B, Wilton P, Wüster C, KIMS International Study Board of KIMS Study Group. Eur J Endocrinol; 2002 Jan; 146(1):67-74. PubMed ID: 11751070 [Abstract] [Full Text] [Related]
16. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF GROWTH HORMONE DEFICIENCY IN ADULTS AND PATIENTS TRANSITIONING FROM PEDIATRIC TO ADULT CARE. Yuen KCJ, Biller BMK, Radovick S, Carmichael JD, Jasim S, Pantalone KM, Hoffman AR. Endocr Pract; 2019 Nov; 25(11):1191-1232. PubMed ID: 31760824 [Abstract] [Full Text] [Related]
20. The influence of gender on the short and long-term effects of growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults: a 5-year study. Drake WM, Rodríguez-Arnao J, Weaver JU, James IT, Coyte D, Spector TD, Besser GM, Monson JP. Clin Endocrinol (Oxf); 2001 Apr; 54(4):525-32. PubMed ID: 11318789 [Abstract] [Full Text] [Related] Page: [Next] [New Search]